Topline results were announced from a second phase 3 trial evaluating AD109 (aroxybutynin 2.5mg/atomoxetine 75mg) in patients with OSA.

New research has revealed factors associated with an increased risk of COVID-19-related death and hospitalization among patients with cancer.

HHS Secretary RFK Jr is considering removing all 16 members of an advisory group that helps decide which preventive services should be fully covered by insurance.

The US Environmental Protection Agency is looking to remove the legal underpinning for most regulations against climate change.

Ritz peanut butter cracker sandwiches are being recalled due to the possible presence of undeclared peanuts, a major allergen.

The controversial preservative thimerosal will be stripped from all flu vaccines distributed in the United States.

A broad spectrum of systemic inflammatory manifestations defines VEXAS syndrome, with cutaneous, respiratory, and vascular involvement commonly reported.

A QI project shows that the establishment of an interdisciplinary Code Sepsis Team can improve compliance with sepsis bundle ...

Among children studied, causes of bronchiectasis were most commonly post-infective (31%), primary and secondary immunodeficiencies (19%), and genetic (13%). Children and teens with bronchiectasis and ...

Deep learning models had high sensitivity in screening for pulmonary hypertension and congenital heart disease–associated PAH.

Despite near universal availability of nirsevimab, only 35% of eligible children receive nirsevimab for RSV prophylaxis.

The Food and Drug Administration has granted Fast Track Designation to ateganosine for the treatment of non-small cell lung cancer.